Literature DB >> 18613118

Multipoint lods provide reliable linkage evidence despite unknown limiting distribution: type I error probabilities decrease with sample size for multipoint lods and mods.

Susan E Hodge1, Laura Rodriguez-Murillo, Lisa J Strug, David A Greenberg.   

Abstract

We investigate the behavior of type I error rates in model-based multipoint (MP) linkage analysis, as a function of sample size (N). We consider both MP lods (i.e., MP linkage analysis that uses the correct genetic model) and MP mods (maximizing MP lods over 18 dominant and recessive models). Following Xing and Elston (2006 Genet. Epidemiol, 30: 447-458), we first consider MP linkage analysis limited to a single position; then we enlarge the scope and maximize the lods and mods over a span of positions. In all situations we examined, type I error rates decrease with increasing sample size, apparently approaching zero. We show: (a) For MP lods analyzed only at a single position, well-known statistical theory predicts that type I error rates approach zero. (b) For MP lods and mods maximized over position, this result has a different explanation, related to the fact that one maximizes the scores over only a finite portion of the parameter range. The implications of these findings may be far-reaching: Although it is widely accepted that fixed nominal critical values for MP lods and mods are not known, this study shows that whatever the nominal error rates are, the actual error rates appear to decrease with increasing sample size. Moreover, the actual (observed) type I error rate may be quite small for any given study. We conclude that MP lod and mod scores provide reliable linkage evidence for complex diseases, despite the unknown limiting distributions of these MP scores.

Entities:  

Mesh:

Year:  2008        PMID: 18613118      PMCID: PMC2673999          DOI: 10.1002/gepi.20350

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  9 in total

1.  Determining trait locus position from multipoint analysis: accuracy and power of three different statistics.

Authors:  D A Greenberg; P C Abreu
Journal:  Genet Epidemiol       Date:  2001-12       Impact factor: 2.135

Review 2.  Likelihood methods for measuring statistical evidence.

Authors:  Jeffrey D Blume
Journal:  Stat Med       Date:  2002-09-15       Impact factor: 2.373

3.  Man bites dog? The validity of maximizing lod scores to determine mode of inheritance.

Authors:  R C Elston
Journal:  Am J Med Genet       Date:  1989-12

4.  Model misspecification and multipoint linkage analysis.

Authors:  N Risch; L Giuffra
Journal:  Hum Hered       Date:  1992       Impact factor: 0.444

5.  An alternative foundation for the planning and evaluation of linkage analysis. I. Decoupling "error probabilities" from "measures of evidence".

Authors:  Lisa J Strug; Susan E Hodge
Journal:  Hum Hered       Date:  2006-07-25       Impact factor: 0.444

6.  Distribution and magnitude of type I error of model-based multipoint lod scores: implications for multipoint mod scores.

Authors:  Chao Xing; Robert C Elston
Journal:  Genet Epidemiol       Date:  2006-07       Impact factor: 2.135

7.  MOD-score analysis with simple pedigrees: an overview of likelihood-based linkage methods.

Authors:  Konstantin Strauch
Journal:  Hum Hered       Date:  2007-05-25       Impact factor: 0.444

8.  Magnitude of type I error when single-locus linkage analysis is maximized over models: a simulation study.

Authors:  S E Hodge; P C Abreu; D A Greenberg
Journal:  Am J Hum Genet       Date:  1997-01       Impact factor: 11.025

9.  Lods, wrods, and mods: the interpretation of lod scores calculated under different models.

Authors:  S E Hodge; R C Elston
Journal:  Genet Epidemiol       Date:  1994       Impact factor: 2.135

  9 in total
  9 in total

1.  Computer simulation is an undervalued tool for genetic analysis: a historical view and presentation of SHIMSHON--a Web-based genetic simulation package.

Authors:  David A Greenberg
Journal:  Hum Hered       Date:  2011-12-23       Impact factor: 0.444

2.  Using parametric multipoint lods and mods for linkage analysis requires a shift in statistical thinking.

Authors:  Susan E Hodge; Zeynep Baskurt; Lisa J Strug
Journal:  Hum Hered       Date:  2011-12-23       Impact factor: 0.444

Review 3.  Linkage analysis in the next-generation sequencing era.

Authors:  Joan E Bailey-Wilson; Alexander F Wilson
Journal:  Hum Hered       Date:  2011-12-23       Impact factor: 0.444

4.  Genome-wide linkage scan for prostate cancer susceptibility in Finland: evidence for a novel locus on 2q37.3 and confirmation of signal on 17q21-q22.

Authors:  Cheryl D Cropp; Claire L Simpson; Tiina Wahlfors; Nati Ha; Asha George; MaryPat S Jones; Ursula Harper; Damaris Ponciano-Jackson; Tiffany A Green; Teuvo L J Tammela; Joan Bailey-Wilson; Johanna Schleutker
Journal:  Int J Cancer       Date:  2011-04-20       Impact factor: 7.396

5.  The essence of linkage-based imprinting detection: comparing power, type 1 error, and the effects of confounders in two different analysis approaches.

Authors:  David A Greenberg; Maria Cristina Monti; Bjarke Feenstra; Junying Zhang; Susan E Hodge
Journal:  Ann Hum Genet       Date:  2010-03-31       Impact factor: 1.670

6.  Distribution of model-based multipoint heterogeneity lod scores.

Authors:  Chao Xing; Nathan Morris; Guan Xing
Journal:  Genet Epidemiol       Date:  2010-12       Impact factor: 2.135

Review 7.  How should we be searching for genes for common epilepsy? A critique and a prescription.

Authors:  David A Greenberg; William C L Stewart
Journal:  Epilepsia       Date:  2012-09       Impact factor: 5.864

8.  False-positive rates in two-point parametric linkage analysis.

Authors:  Silke Szymczak; Claire L Simpson; Cheryl D Cropp; Joan E Bailey-Wilson
Journal:  BMC Proc       Date:  2014-06-17

9.  A powerful test of independent assortment that determines genome-wide significance quickly and accurately.

Authors:  W C L Stewart; V R Hager
Journal:  Heredity (Edinb)       Date:  2016-06-01       Impact factor: 3.821

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.